The Impact of Emerging Dolutegravir Resistance on Global HIV Treatment and Prevention
Today's Clinical Lab, Thermo Fisher Scientific
Dr. Obiageli Okafor discusses growing resistance to dolutegravir and the need for global access to affordable HIV treatment and prevention